Reduced All‐Cause Mortality With Bisphosphonates Among Post‐Fracture Osteoporosis Patients: A Nationwide Study and Systematic Review

Author:

Hsu Yu‐Hsuan1,Li Chia‐Chun23ORCID,Liang Fu‐Wen4,Peng Zi‐Yang1,Chang Yin‐Fan5,Hsu Jason C.6789,Ou Huang‐Tz110ORCID,Wu Chih‐Hsing3511ORCID

Affiliation:

1. Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine National Cheng Kung University Tainan Taiwan

2. Institute of Allied Health Sciences, College of Medicine National Cheng Kung University Tainan Taiwan

3. Department of Family Medicine, College of Medicine National Cheng Kung University Tainan Taiwan

4. Department of Public Health, College of Health Sciences Kaohsiung Medical University Kaohsiung Taiwan

5. Department of Family Medicine National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University Tainan Taiwan

6. International Ph.D. Program in Biotech and Healthcare Management, College of Management Taipei Medical University Taipei Taiwan

7. Clinical Data Center, Office of Data Science Taipei Medical University Taipei Taiwan

8. Research Center of Data Science on Healthcare Industry, College of Management Taipei Medical University Taipei Taiwan

9. Clinical Big Data Research Center Taipei Medical University Hospital, Taipei Medical University Taipei Taiwan

10. Department of Pharmacy, College of Medicine National Cheng Kung University Tainan Taiwan

11. Institute of Gerontology, College of Medicine National Cheng Kung University Tainan Taiwan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3